LYNN SWAFFORD: Open Payments
NPI 1174918445 · RIVERSIDE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 27 payments from 9 companies in 2025. Trend: 2023 $1,449 · 2024 $1,262 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $84 |
| ABBVIE INC. | 5 | $80 |
| Amgen Inc. | 4 | $73 |
| PFIZER INC. | 4 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $58 |
| Almirall LLC | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| GENZYME CORPORATION | 1 | $26 |
Products named: Bimzelx, OTEZLA, CIBINQO, RINVOQ, BLU-U, Seysara, Sotyktu, DUPIXENT.
Industry payments across MO — which companies pay providers there.
